These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22342865)

  • 1. Guidelines for implantation of primary prevention defibrillators: who is listening?
    Markowitz SM
    Heart Rhythm; 2012 Jun; 9(6):882-3. PubMed ID: 22342865
    [No Abstract]   [Full Text] [Related]  

  • 2. Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey.
    Castellanos JM; Smith LM; Varosy PD; Dehlendorf C; Marcus GM
    Heart Rhythm; 2012 Jun; 9(6):874-81. PubMed ID: 22306794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low referral pattern for implantable defibrillator therapy in a tertiary hospital: referral physician survey and Monte Carlo simulation.
    Mohamad T; Jacob S; Kommuri NV; Modi S; Aravindhakshan R; Lieberman R
    Am J Ther; 2011 Sep; 18(5):350-4. PubMed ID: 20335787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing physician knowledge regarding indications for a primary prevention implantable defibrillator and potential barriers for referral.
    Bernier R; Raj SR; Tran D; Reyes L; Sauve M; Sumner GL; Exner DV; Sandhu RK
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1334-1341. PubMed ID: 28841249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consideration of patient age and life expectancy in implantable cardioverter-defibrillator referral.
    Dewland TA; Hsu JC; Castellanos JM; Smith LM; Marcus GM
    Am Heart J; 2013 Jul; 166(1):164-70. PubMed ID: 23816036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Many cardiac devices implanted contrary to guidelines.
    Wilson L
    Am J Nurs; 2011 Apr; 111(4):15. PubMed ID: 21451284
    [No Abstract]   [Full Text] [Related]  

  • 7. Awareness of indications for device therapy among a broad range of physicians: a survey study.
    Hübinette C; Lund LH; Gadler F; Ståhlberg M
    Europace; 2014 Nov; 16(11):1580-6. PubMed ID: 24451291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the appropriateness of ICD use "appropriately".
    Al-Khatib SM
    Heart Rhythm; 2015 Oct; 12(10):2094-5. PubMed ID: 26054309
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing Variation in Implantable Cardioverter Defibrillator Therapy Guideline Adherence With Physician and Hospital Patient-sharing Networks.
    Moen EL; Bynum JP; Austin AM; Skinner JS; Chakraborti G; O'Malley AJ
    Med Care; 2018 Apr; 56(4):350-357. PubMed ID: 29419707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to patients eligible for screening investigations and insertion of primary prevention implantable cardioverter defibrillators.
    Sadarmin PP; Wong KC; Rajappan K; Bashir Y; Betts TR
    Europace; 2014 Nov; 16(11):1575-9. PubMed ID: 24668515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ICD therapy in the primary prevention of sudden cardiac death: Risk stratification and patient selection].
    Neuzner J; Gradaus R
    Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):75-81. PubMed ID: 26041117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should the Subcutaneous Implantable Defibrillator Be the First Choice for Primary Prevention of Sudden Cardiac Death?
    Knops RE; Brouwer TF
    Rev Esp Cardiol (Engl Ed); 2017 Mar; 70(3):142-144. PubMed ID: 27838348
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary prevention implantable cardioverter-defibrillators: they work in the real world, too.
    Lampert R
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):624-5. PubMed ID: 22895600
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of a Reminder Statement on Echocardiography Reports on Referrals for Implantable Cardioverter-Defibrillators for Primary Prevention.
    Chokshi M; McNamara RL; Rajeswaran Y; Lampert R
    Am J Cardiol; 2017 Feb; 119(3):478-482. PubMed ID: 27939224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillators not for everyone. But not all physicians follow criteria for patient implantation, analysis shows.
    Duke Med Health News; 2011 Mar; 17(3):1-2. PubMed ID: 21476239
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
    Gravelin LM; Yuhas J; Remetz M; Radford M; Foley J; Lampert R
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):152-6. PubMed ID: 21304093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter defibrillator patients: insight from Danish nationwide registers.
    Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Petersen HH; Torp-Pedersen C; Riahi S; Jøns C
    Europace; 2018 Feb; 20(2):301-307. PubMed ID: 28339659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New options to reboot the heart. Implantable cardioverter-defibrillators can prevent sudden cardiac arrest. Now more people can benefit.
    Harv Heart Lett; 2014 Feb; 24(6):6. PubMed ID: 24804347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.